期刊文献+

Synthesis of highly concentrated,carrier free ^(188)Re-mercaptoacetyltriglycine 被引量:1

Synthesis of highly concentrated, carrier free ^(188)Re-mercaptoacetyltriglycine
下载PDF
导出
摘要 Chelation of 188Re to compounds such as MAG3 will further reduce the radiation dose to the patient in case of balloon rupture through the rapid excretion from the body. In order to prepare highly concentrated, carrier free 188Re-MAG3, Sbenzoyl mercaptoacetyltriglycine (S-Bz-MAG3) was synthesized, labeled with carrier free 188Re. The overall yield of S-Bz-MAG3 is higher than those published in theliterature. Dependence of the labeling yield of 1ssRe-MAG3 upon concentrations of reducing agent, pH, reaction time, etc. was examined and optimum conditions were confirmed. The concentration procedure was succeeded with Sep-Pak C18 cartridge to obtain highly concentrated 1s8Re-MAG3. In the case of optimun conditions, the labeling yield of 188Re-MAG3 was more than 98%. Radiochemical purity of 188ReMAG3 was more than 92% after 24 hour storage at room temperature. Chelation of 188Re to compounds such as MAG3 will further reduce the radiation dose to the patient in case of balloon rupture through the rapid excretion from the body. In order to prepare highly concentrated, carrier free 188Re-MAG3, S-benzoyl mercaptoacetyltriglycine (S-Bz-MAG3) was synthesized, labeled with carrier free 188Re. The overall yield of S-Bz-MAG3 is higher than those published in the literature. Dependence of the labeling yield of 188Re-MAG3 upon concentrations of reducing agent, pH, reaction time, etc. was examined and optimum conditions were confirmed. The concentration procedure was succeeded with Sep-Pak C18 cartridge to obtain highly concentrated 188Re-MAG3. In the case of optimun conditions, the labeling yield of 188Re-MAG3 was more than 98%. Radiochemical purity of 188Re-MAG3 was more than 92% after 24 hour storage at room temperature.
出处 《Nuclear Science and Techniques》 SCIE CAS CSCD 2002年第4期237-243,共7页 核技术(英文)
基金 Supported partially by Key Project of Knowledge Innvation Program of the Chinese Academy of Sciences (KJCX1-sw-08)
关键词 放射同位素 ^188RE 放射免疫疗法 188Re-MAG3, Synthesis, Labeling, Carrier free, RIT
  • 相关文献

参考文献12

  • 1Yin D Z, Yu J F, Wang Y X. Nucl Tech (in Chinese), 2000, 23:347-352
  • 2Yin D Z, Guo Z L, Zhang J et al. Nucl Tech (in Chinese), 1999, 22:374 377
  • 3Ding Z G, Yu J F, Yin D Z et al. Nucl Tech (in Chinese), 2000, 23:762 766
  • 4Yu J F, Yin D Z, Min X F et al. J Labelled Compd Radiopham, 1999, 42:233-243
  • 5Lin Y W, Wei H P, Zhang X L et al. Nucl Tech (accepted)
  • 6Fritzberg A R, Kasina S, Eshima D et al. J Nucl Med, 1986, 27:111-116
  • 7Gog Frank B, Visser G W M, Klok R et al. J Nucl Med, 1996, 37:352-362
  • 8Guhlke S, Schaffland A, Zamora P O et al. Nucl Med Biol, 1998, 25:621-631
  • 9Yin D Z, Hu W Q, Cai X M et al. Nucl Tech (in Chinese), 1998, 21:51-55
  • 10Brandau W, Bubeck B, Eisenhut M et al. Appl Radiat Isot, 1988, 39:121-129

同被引文献3

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部